The emergence of medications like copyright and Semaglutide signifies a significant shift in how we approach type 2 diabetes. These innovative therapies belong to a class known as GLP-1 receptor agonists, which replicate the effects of a natural hormone that regulates glucose levels and appetite. First, developed for managing blood sugar, their eff